CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
stannous fluoridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02752958
NCT02752958N/ACompleted
CompareCT.gov

Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity With a Daily Use Anti-Sensitivity Toothpaste

GlaxoSmithKline·interventional·Posted Apr 27, 2016·Updated Aug 27, 2018

In Brief

A clinical study evaluating stannous fluoride for Dentin Sensitivity. Completed, enrolled 75 participants across 2 sites.

Detailed Summary

This multicentre, non-comparative design study will monitor the impact of long term management of DH with daily use of a sensitivity toothpaste on the quality of life of a population of sensitivity sufferers. Changes in oral health related quality of life will be monitored using the Dentine Hypersensitivity Experience Questionnaire (DHEQ). The study will be conducted in participants in good general health, with pre-existing self-reported and clinically diagnosed tooth sensitivity at screening.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 27, 2016
Enrollment StartMay 23, 2016
Primary CompletionFeb 1, 2017
Study CompletionFeb 3, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.2 years ago

Interventions

stannous fluoridedrug

0.454% w/w (weight per weight) stannous fluoride